Skip to content
Aperlena
Free alerts

Tender notices: Germany, August 2025

August 2025, Germany: 72 notices, each with a page of its own here. This page lists 72 of them: 4 Aug 2025 to 28 Aug 2025. They come from 18 contracting authorities. The sector with the most of them here: Medical equipment & pharmaceuticals.

Statistics: August 2025 All months: Germany Search tenders: Germany

Published Notice Buyer est. value
4 Aug Medicines - Discount agreements for medicines from 01.06.2025 for various active substances under an open-house procedure AOK NordWest
4 Aug Medicines - Non-exclusive rebate agreement under Section 130a Para. 8 SGB V for medicines with the active ingredient natalizumab (ATC code L04AG03) AOK Niedersachsen. Die Gesundheitskasse.
4 Aug Medicines - Non-exclusive rebate contract under Section 130a(8) SGB V for medicines with the active ingredient golimumab (ATC code L04AB06) AOK Niedersachsen. Die Gesundheitskasse.
5 Aug Medicines - Open house discount agreements for the active ingredient aclidinium bromide, ATC R03BB05 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Conclusion of non-exclusive rebate agreements under § 130a (8) SGB V for the named active substances, with the option to join via an Open House procedure KKH Kaufmännische Krankenkasse
5 Aug Medicines - Open house rebate contracts for the active substance Octreotide, ATC H01CB02 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Open house rebate contracts for the active ingredient Follitropin beta, ATC G03GA06 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V from 01/09/2025 GWQ ServicePlus AG
5 Aug Medicines - Open house rebate agreements for the active substance Nitisinone, ATC A16AX04 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Open house discount agreements for the active substance Olodaterol and Tiotropiumbromide, ATC R03AL06 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Open house rebate agreements for the active substance Flupentixol, ATC N05AF01 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
5 Aug Medicines - Open house discount agreements for the active substance Tramadol and Paracetamol, ATC N02AJ13 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
6 Aug Medicines - Non-exclusive rebate agreements under §130a(8) SGB V for parenteral nutrition solutions (ATC code: B05BA10) GWQ ServicePlus AG
7 Aug Medicinal products - Open-House biologics discount agreements 2025-22 - Triptorelin embonate Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse
7 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a para. 8 SGB V for various active substances and combinations via the Open House procedure AOK Nordost. Die Gesundheitskasse.
7 Aug Medical aids - Open framework agreement on discounts under § 130a paragraph 8 SGB V with joining possible at any time, so-called admission model, for blood glucose test strips for the federal state of North Rhine-Westphalia Deutsche Rentenversicherung Knappschaft-Bahn-See
10 Aug Fire service vehicles - Delivery of one demonstration vehicle HLF20 Rennbahngemeinde Hoppegarten
10 Aug Medicines - Open framework agreement on medicine discounts under Section 130a(8) SGB V with option to join at any time, so-called admission model 2025-08 Deutsche Rentenversicherung Knappschaft-Bahn-See
11 Aug Medicinal products - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for various active substances and combinations, open house procedure with accession possible at any time AOK Nordost. Die Gesundheitskasse.
11 Aug Medicines - Conclusion of a non-exclusive rebate contract under Section 130a Paragraph 8 SGB V for medicines containing the active ingredient Eltrombopag (ATC code: B02BX05) AOK Niedersachsen. Die Gesundheitskasse.
13 Aug Medicines - Open house discount agreements for medicines, Colchicine, ATC M04AC01 AOK Bayern - Die Gesundheitskasse
13 Aug Medicines - Open house rebate agreements for Anakinra, ATC L04AC03 AOK Bayern - Die Gesundheitskasse
13 Aug Medicines - Open house rebate agreements for eltrombopag, excluding the indication severe aplastic anaemia in the summary of product characteristics unless the manufacturer holds patent protection, ATC B02BX05 AOK Bayern - Die Gesundheitskasse
13 Aug Medicines - Open house rebate agreements for leuprorelin, ATC L02AE02 AOK Bayern - Die Gesundheitskasse
13 Aug Medicines - Open house discount agreements for Dornase alfa (Desoxyribonuclease), ATC R05CB13 AOK Bayern - Die Gesundheitskasse
13 Aug Medicines - Open house rebate agreements Omalizumab, ATC R03DX05 AOK Bayern - Die Gesundheitskasse
17 Aug Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V for biosimilar active ingredients from 01.10.2025 GWQ ServicePlus AG
17 Aug Medicines - Open house rebate agreements for the active substance Eltrombopag, ATC B02BX05 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
18 Aug Medicines - Conclusion of a non-exclusive rebate agreement under § 130a (8) SGB V for the active ingredient house dust mite allergen extract (excluding Orylmyte), ATC V01AA03, for 01.10.2025 - 30.09.2027 DAK-Gesundheit
18 Aug Medicines - Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Relugolix, ATC L02BX04, for the period 01.10.2025 - 30.09.2027 DAK-Gesundheit
18 Aug Medicines - Medicines discount agreement from 01.10.2025 for the active substance combination Naproxen & Esomeprazole in an Open-House procedure AOK NordWest
18 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Cariprazine, ATC N05AX15, from 01.10.2025 to 30.09.2027 DAK-Gesundheit
18 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active ingredients, with the option to join under the so-called open-house procedure. KKH Kaufmännische Krankenkasse
18 Aug Medicines - Open-House Biosimilar Discount Agreements 2025-23 - Etanercept Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Kaufmännische Krankenkasse (KKH); DAK-Gesundheit (DAK-G)
18 Aug Medicines - Conclusion of non-exclusive rebate agreements under § 130a (8) SGB V for the active substance Tacrolimus, ATC D11AH01, from 01.10.2025 to 30.09.2027 DAK-Gesundheit
18 Aug Medicines - Open House Originale discount agreements 2025-24 - Vericiguat Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse
18 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a Para. 8 SGB V for named active substances, with accession under an open-house procedure KKH Kaufmännische Krankenkasse
18 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a (8) SGB V for the active substance house dust mite allergen extract (excluding Acarizax), ATC V01AA03, for the period 01.10.2025 - 30.09.2027 DAK-Gesundheit
18 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a para. 8 SGB V for the active substance Naloxegol -VV 86 GWQ ServicePlus AG
18 Aug Medicines - Conclusion of non-exclusive discount agreements under Section 130a Para. 8 SGB V for various active substances/combinations with open-house participation possible at any time AOK Nordost. Die Gesundheitskasse.
18 Aug Medicines - Discount agreements pursuant to Section 130a paragraph 8 SGB V under open-house procedures IKK classic
18 Aug Medicines - Open House Original Rebate Contracts 2025-22 - Aclidinium Bromide Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse
18 Aug Medicines - Non-exclusive rebate agreement under Section 130a (8) SGB V for active substances (medicines) - VV 86 GWQ ServicePlus AG
19 Aug Non-exclusive rebate agreement under § 130a(8) SGB V for dimethylfumarate (240 mg, N3 only), ATC L04AX07, 01.10.2025 to 30.09.2027 with one 12-month extension DAK-Gesundheit
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Teriflunomid, ATC L04AK02, for the period 01.10.2025 - 31.12.2025 (plus one 12-month extension option) DAK-Gesundheit
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active ingredient hydrocortisone (tablet form only), ATC H02AB09, for the period 01.10.2025 to 30.09.2027 (plus extension option of 1 x 12 months) DAK-Gesundheit
19 Aug Medicines - Open-house rebate contracts 2025-10 Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
19 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances via an Open House procedure KKH Kaufmännische Krankenkasse
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under § 130a (8) SGB V for the active substance ferrous sulfate, ATC B03AA07, for the period 01.10.2025 - 30.09.2027 (plus extension option 1 x 12 months) DAK-Gesundheit
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under § 130a para. 8 SGB V for the active substance Colesevelam, ATC C10AC04, for the period 01.10.2025 - 30.09.2027 (plus extension option 1x12 months) DAK-Gesundheit
19 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a (8) SGB V for the named active substances, with the option to join under the so-called Open House procedure KKH Kaufmännische Krankenkasse
19 Aug Medicines - Discount agreements pursuant to Section 130a (8) SGB V as part of open-house procedures IKK classic
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Eltrombopag (patent-free indications), ATC B02BX05, from 01.10.2025 to 30.09.2027 (plus extension option 1x12 months) DAK-Gesundheit
19 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances, with the option to join under the Open-House procedure KKH Kaufmännische Krankenkasse
19 Aug Medicines - Conclusion of a non-exclusive rebate agreement under § 130a(8) SGB V for the active ingredient Calcium carbonate + Colecalciferol, ATC A12AX01 for the period 01.10.25-30.09.27 (plus extension option 1 x 12 months) DAK-Gesundheit
20 Aug Medicines - Conclusion of non-exclusive discount agreements under Section 130a (8) SGB V (Open House model) AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/
20 Aug Medicines - Pharmaceutical contracts with option to accede BARMER Beschaffung und Vergabe
20 Aug Pharmaceutical rebate agreements under Section 130a para. 8 SGB V via open-house procedure IKK classic
21 Aug Medicines - Open House Originale rebate contracts 2025-25 - Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (active substance combination) Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse
21 Aug Medicines - Open house discount agreements for the active substance rivaroxaban, film-coated tablets only, excluding the 2.5 mg strength, ATC B01AF01 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
24 Aug Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V via an open-house model for the active substance Brinzolamide/Brimonidine (ATC code S01EC24) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
24 Aug Medicines - Conclusion of non-exclusive rebate agreements on medicinal products under Section 130a (8) SGB V via an open-house model for the active ingredient Certolizumab pegol (WHO ATC code: L04AB05) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
24 Aug Medicinal products - Medicinal products with the active ingredient Eltrombopag (ATC: B02BX05) AOK Sachsen - Anhalt
25 Aug Medicines - Open-house rebate contracts 2025-11 - Eltrombopag Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
25 Aug Medicinal products - Medicinal products with the active substance Rivaroxaban (ATC: B01AF01 - all strengths except 2.5 mg per subdivided oral dosage form) AOK Sachsen - Anhalt
25 Aug Medicines - Pharmaceutical contracts with accession option BARMER Beschaffung und Vergabe
26 Aug Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V for the listed active substances with accession under the so-called Open-House procedure KKH Kaufmännische Krankenkasse
27 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a (8) SGB V for the listed active ingredients via an open house procedure KKH Kaufmännische Krankenkasse
28 Aug Medicines - Open framework agreements on medicine discounts under § 130a paragraph 8 SGB V with open-ended accession option, the so-called 'Zulassungsmodell 2025-02' of Deutsche Rentenversicherung Knappschaft-Bahn-See Deutsche Rentenversicherung Knappschaft-Bahn-See
28 Aug Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V via an open-house model for the active ingredient tacrolimus (ATC code per WHO: D11AH01) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
28 Aug Medicines - Conclusion of non-exclusive discount agreements on medicinal products under Section 130a Para. 8 SGB V via an open-house model for the active ingredient pancreatin (WHO ATC code: A09AA02) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
28 Aug Medicines - Conclusion of non-exclusive rebate agreements for medicines under Section 130a (8) SGB V via an open-house model for the active substance Tacrolimus (ATC code L04AD02) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language